Cargando…

Ferroptosis as an emerging target in rheumatoid arthritis

Rheumatoid arthritis (RA) is an autoimmune disease of unknown etiology. Due to the rise in the incidence rate of RA and the limitations of existing therapies, the search for new treatment strategies for RA has become a global focus. Ferroptosis is a novel programmed cell death characterized by iron-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Hui, Tang, Cheng, Wang, Miao, Zhao, Hongfang, Zhu, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620966/ https://www.ncbi.nlm.nih.gov/pubmed/37928554 http://dx.doi.org/10.3389/fimmu.2023.1260839

Ejemplares similares

Ferroptosis in Rheumatoid Arthritis: A Potential Therapeutic Strategy
por: Zhao, Ting, et al.
Publicado: (2022)

Identification of potential ferroptosis-associated biomarkers in rheumatoid arthritis
por: He, Xu, et al.
Publicado: (2023)

T-Follicular Regulatory Cells: Potential Therapeutic Targets in Rheumatoid Arthritis
por: Ding, Tingting, et al.
Publicado: (2019)

Lipid metabolism and rheumatoid arthritis
por: Lei, Qian, et al.
Publicado: (2023)

Ferroptosis in inflammatory arthritis: A promising future
por: Chang, Siyuan, et al.
Publicado: (2022)

Regulatory role of KCa3.1 in immune cell function and its emerging association with rheumatoid arthritis
por: Lin, Yi, et al.
Publicado: (2022)

Rheumatoid meningitis: a rare neurological complication of rheumatoid arthritis
por: Fan, Siyuan, et al.
Publicado: (2023)

Inflammasome and Its Therapeutic Targeting in Rheumatoid Arthritis
por: Jiang, Qi, et al.
Publicado: (2022)

LncRNA Expression Profiles in Systemic Lupus Erythematosus and Rheumatoid Arthritis: Emerging Biomarkers and Therapeutic Targets
por: Wu, Han, et al.
Publicado: (2021)

Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis
por: Huang, Jie, et al.
Publicado: (2021)

Advancement in understanding the role of ferroptosis in rheumatoid arthritis
por: Long, Li, et al.
Publicado: (2022)

Emerging Role of Endosomal Toll-Like Receptors in Rheumatoid Arthritis
por: Thwaites, Ryan, et al.
Publicado: (2014)

DNA Methylation of T Lymphocytes as a Therapeutic Target: Implications for Rheumatoid Arthritis Etiology
por: Zhao, Jianan, et al.
Publicado: (2022)

Chemokines and chemokine receptors as promising targets in rheumatoid arthritis
por: Murayama, Masanori A., et al.
Publicado: (2023)

Targeting transcription factors for therapeutic benefit in rheumatoid arthritis
por: Balendran, Thivya, et al.
Publicado: (2023)

Targeting Activated Synovial Fibroblasts in Rheumatoid Arthritis by Peficitinib
por: Diller, Magnus, et al.
Publicado: (2019)

Proteome Profiling Identifies Serum Biomarkers in Rheumatoid Arthritis
por: Hu, Congqi, et al.
Publicado: (2022)

Natural medicines of targeted rheumatoid arthritis and its action mechanism
por: Liu, Xueling, et al.
Publicado: (2022)

Metabolomics in rheumatoid arthritis: Advances and review
por: Xu, Lingxia, et al.
Publicado: (2022)

Can pyroptosis be a new target in rheumatoid arthritis treatment?
por: Wu, Dengqiang, et al.
Publicado: (2023)

Assessing the association of leukocyte telomere length with ankylosing spondylitis and rheumatoid arthritis: A bidirectional Mendelian randomization study
por: Wei, Donglei, et al.
Publicado: (2023)

Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis
por: Zhou, Tao-tao, et al.
Publicado: (2023)

Epigenetic Regulation of Immune and Inflammatory Responses in Rheumatoid Arthritis
por: Chen, Qi, et al.
Publicado: (2022)

Dyslipidemia in rheumatoid arthritis: the possible mechanisms
por: Yan, Jiahui, et al.
Publicado: (2023)

Analysis and Experimental Validation of Rheumatoid Arthritis Innate Immunity Gene CYFIP2 and Pan-Cancer
por: Zhao, ZhenYu, et al.
Publicado: (2022)

Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities
por: Zhao, Ting, et al.
Publicado: (2022)

Role of NLRP3 Inflammasome in Rheumatoid Arthritis
por: Yin, Hui, et al.
Publicado: (2022)

Ferroptosis: the emerging player in remodeling triple-negative breast cancer
por: Li, Jie, et al.
Publicado: (2023)

Role of reactive oxygen species and mitochondrial damage in rheumatoid arthritis and targeted drugs
por: Jing, Weiyao, et al.
Publicado: (2023)

Reestablish immune tolerance in rheumatoid arthritis
por: Shuai, Ziqiang, et al.
Publicado: (2022)

Th1-Like Treg Cells Are Increased But Deficient in Function in Rheumatoid Arthritis
por: Zhang, Rui, et al.
Publicado: (2022)

Migration and homeostasis of regulatory T cells in rheumatoid arthritis
por: Kotschenreuther, Konstantin, et al.
Publicado: (2022)

Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis
por: Zhao, Jianan, et al.
Publicado: (2021)

Editorial: The innate immune system in rheumatoid arthritis
por: Chen, Zhu, et al.
Publicado: (2022)

Loss of Smad7 Promotes Inflammation in Rheumatoid Arthritis
por: Zhou, Gengmin, et al.
Publicado: (2018)

Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
por: Zhao, Jianan, et al.
Publicado: (2021)

T Cell Migration in Rheumatoid Arthritis
por: Mellado, Mario, et al.
Publicado: (2015)

The bridge of the gut–joint axis: Gut microbial metabolites in rheumatoid arthritis
por: Xu, Xiaoyu, et al.
Publicado: (2022)

Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment
por: Wu, Di, et al.
Publicado: (2022)

Ferroptosis-Related Molecular Clusters and Diagnostic Model in Rheumatoid Arthritis
por: Xie, Maosheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o8m7l3i7q8jrknoa2ojm5p5bhq